Healthcare provider profile · identity verified

Eladio M Chatto, MD

Internal Medicine · ROSICLARE, IL · NPI 1376543702

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	375	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	323	50
Amlodipine Besylate	Amlodipine Besylate	251	59
Lisinopril	Lisinopril	242	59
Omeprazole	Omeprazole	234	47
Metformin Hcl	Metformin Hcl	190	44
Pantoprazole Sodium	Pantoprazole Sodium	178	45
Carvedilol	Carvedilol	171	39
Potassium Chloride	Potassium Chloride	171	38
Furosemide	Furosemide	162	41
Losartan Potassium	Losartan Potassium	159	42
Famotidine	Famotidine	150	39
Gabapentin	Gabapentin	149	26
Eliquis	Apixaban	148	22
Levothyroxine Sodium	Levothyroxine Sodium	148	30
Metoprolol Tartrate	Metoprolol Tartrate	142	33
Metoprolol Succinate	Metoprolol Succinate	138	29
Spironolactone	Spironolactone	125	23
Rosuvastatin Calcium	Rosuvastatin Calcium	100	24
Tamsulosin Hcl	Tamsulosin Hcl	89	24
Xarelto	Rivaroxaban	87	12
Fluticasone Propionate	Fluticasone Propionate	81	19
Lorazepam	Lorazepam	74	13
Simvastatin	Simvastatin	72	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	71	21
Duloxetine Hcl	Duloxetine Hcl	71	13
Alprazolam	Alprazolam	68	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	66	17
Clonazepam	Clonazepam	65	suppressed
Glimepiride	Glimepiride	64	13
Jardiance	Empagliflozin	64	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	58	suppressed
Pravastatin Sodium	Pravastatin Sodium	58	13
Prednisone	Prednisone	53	27
Ezetimibe	Ezetimibe	52	14
Clopidogrel	Clopidogrel Bisulfate	50	18
Allopurinol	Allopurinol	47	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	14
Ropinirole Hcl	Ropinirole Hcl	46	13
Januvia	Sitagliptin Phosphate	45	suppressed
Tramadol Hcl	Tramadol Hcl	45	suppressed
Warfarin Sodium	Warfarin Sodium	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	11
Amoxicillin	Amoxicillin	41	32
Azithromycin	Azithromycin	38	32
Digoxin	Digoxin	38	suppressed
Clonidine Hcl	Clonidine Hcl	37	11
Cephalexin	Cephalexin	35	31
Methylprednisolone	Methylprednisolone	35	32
Mirtazapine	Mirtazapine	35	suppressed
Nebivolol Hcl	Nebivolol Hcl	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	12
Memantine Hcl	Memantine Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	11
Ondansetron Hcl	Ondansetron Hcl	33	11
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Finasteride	Finasteride	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Atenolol	Atenolol	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Sucralfate	Sucralfate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Nystatin	Nystatin	26	17
Carbamazepine	Carbamazepine	24	suppressed
Cefdinir	Cefdinir	24	21
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	15
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Namzaric	Memantine Hcl/Donepezil Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Glipizide Er	Glipizide	18	suppressed
Lactulose	Lactulose	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Brilinta	Ticagrelor	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Fluconazole	Fluconazole	16	13
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Levofloxacin	Levofloxacin	16	14
Metformin Hcl Er	Metformin Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Topiramate	Topiramate	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Zafirlukast	Zafirlukast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error